7/30/2021 7:05:10 AM
NuVasive Receives Latest FDA 510(k) Clearance For Pulse Platform
7/28/2021 4:15:42 PM
NuVasive Reports Q2 EPS Of $0.03 Vs. Loss Per Share Of $0.95 Last Year
6/30/2021 7:04:04 AM
NuVasive Gets CE Mark Approval For Pulse Platform; Clinical Evaluations Underway In Multiple Countries Throughout Europe
5/10/2021 4:04:12 PM
NuVasive Appoints Juliet Cunningham As VP Of Investor Relations
5/5/2021 4:04:36 PM
NuVasive Q1 GAAP Loss Per Share $0.15; Non-GAAP EPS $0.37
4/6/2021 4:04:13 PM
NuVasive's Simplify Disc Receives FDA Approval For Two-Level Cervical Total Disc Replacement
3/25/2021 4:05:16 PM
NuVasive Announces Retirement Of Gregory Lucier From Board Of Directors
2/25/2021 4:03:51 PM
NuVasive Q4 GAAP EPS $0.03; Non-GAAP EPS $0.59
2/24/2021 4:03:45 PM
NuVasive Acquires Simplify Medical
2/8/2021 8:35:12 AM
NuVasive Announces Planned Opening Of NuVasive East Coast Experience Center In Englewood, New Jersey, In Q3
2/1/2021 4:09:16 PM
NuVasive Appoints Siddhartha Kadia To Its Board Of Directors